Complex Molecular Etiology and Cellular Landscape of Hip Osteoarthritis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-74
SponsorUniversity of Turku
About this trial
The purpose of this study is to cast light on the highly complex etiology and cellular landscape of hip osteoarthritis by utilising single-cell and spatial omics.
Eligibility criteria
Qualifiers
None
Disqualifiers
The body mass index must be below 35
Age < 18 or > 74
The OA patients may not have diabetes, rheumatoid arthritis (RA), or metabolic syndrome.
Trial design
Treatments tested in this trial
- Total hip arthroplasty
Treatment groups
110 Participants
are divided into 3 treatment groupsLocations
4PET-centre, University of Turku TurkuSouthwest Finland, Finland
Turku Bioscience, University of Turku TurkuSouthwest Finland, Finland
Turku University Hospital TurkuSouthwest Finland, Finland
Helsinki University Hospital EspooUusimaa, Finland
Sponsors and collaborators
University of Turku
Lead sponsor
Turku University Hospital
Collaborator
Hospital District of Helsinki and Uusimaa
Collaborator
Source ClinicalTrials.gov